drugset / Trial / NCT03235180

Ultrasound Evaluation of Crohn's Disease

NCT03235180

Phase 4 Terminated 9 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.

Timeline

Start
2017-06-16
Primary completion
2021-10-12
Completion
2021-10-12

Drugs

EvaluationDrugModalityDoseRoute
Background Lumason Diagnostic / imaging agent 1 ml
Background Lumason Diagnostic / imaging agent 2 ml

Indications